Health Care & Hospitals

Massage Heights Inks Signed Agreement in Ohio with Franchise Business Consultant turned Franchisee

by

Leading Massage and Facial Franchise Expands Footprint in Midwest as Demand for Holistic Care Rises CLEVELAND, Ohio, May 24, 2023 /PRNewswire/ — Massage Heights, a leading massage and wellness franchise, signed a franchise agreement in the Cleveland market, offering resort-quality massage, skincare and wellness services. Already open for business at 18240 Royalton Road in Strongsville, this … Read more

Biopharma-Führungskräfte treffen sich auf dem F&E- und Qualitätsgipfel von Veeva, um Innovationen für die Branche und die Patienten voranzutreiben

by

Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, Syneos Health und weitere Unternehmen  teilen ihre Erkenntnisse zur Steigerung der Effizienz im gesamten Produktentwicklungszyklus BARCELONA, Spanien, 24. Mai 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Führungskräfte von Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati und Syneos Health zu den Rednern des Veeva R&D and Quality … Read more

Accomplished Scientist and Biosurgery Industry Veteran Dr. Neil Winterbottom Joins Medcura’s Leadership Team

by

Dr. Winterbottom will serve the role of SVP, Product Development & Manufacturing Operations RIVERDALE, Md., May 24, 2023 /PRNewswire/ — Medcura, Inc. has added Dr. Neil Winterbottom to its leadership team to accelerate the spine indication approval and commercialization of LifeGel™, Medcura’s flagship surgical hemostat. Medcura, Inc. is delighted to welcome biochemist Dr. Neil Winterbottom … Read more

CAGR of 18.8%.Highlights Positive Outlook

by

COVINA, Calif., May 24, 2023 /PRNewswire/ — According to Prophecy Market Insights Orthodontics Market accounted for US$ 5.4 billion in 2022 and is estimated to be US$ 20.0 billion by 2032 and is anticipated to register a CAGR of 18.8%. Orthodontics is a specialized branch of dentistry that focuses on the diagnosis, prevention, and treatment of … Read more

Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit

by

CAMBRIDGE, Mass., May 24, 2023 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation … Read more

Patient Simulator Market to Reach $1.2 Billion, Globally, by 2032 at 8.7% CAGR: Allied Market Research

by

The global patient simulator market is driven by factors such as rising focus on patient safety, technological advancement, and increase in awareness regarding simulation based education. PORTLAND, Ore., May 24, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Patient Simulator Market by Product Type (Adult Patient Simulator, Infant Simulator, and Childbirth Simulator), Technology … Read more

China’s Aging Society Sparks Pension Interest, Becomes the Next Opportunity for Asset Management Industry

by

HONG KONG and SHANGHAI, May 24, 2023 /PRNewswire/ — China is with great potential and very open for high standard players, says Jacqueline Zhang, Deputy General Manager of Ping An Asset Management Co., Ltd. (“Ping An AMC”), during a panel at the Future of Asset Management Asia event, hosted by the Financial Times in Singapore on … Read more

PRODUCTLIFE GROUP ERWIRBT CILATUS UND ERWEITERT DIE KOMPETENZ IN DER ENTWICKLUNG KOMPLEXER PRODUKTE

by

Nach den Übernahmen von DS InPharmatics (DSI) im Jahr 2021 und Zwiers Regulatory Consultancy im Jahr 2022 baut die ProductLife Group (PLG), ein globaler Anbieter von regulatorischen und Compliance-Dienstleistungen für die Life-Science-Branche, ihre Kapazitäten zur Unterstützung der Produktentwicklungsaktivitäten ihrer Kunden durch die Übernahme des in der Schweiz ansässigen Unternehmens Cilatus Biopharma Consulting und des in … Read more

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

by

Brixadi is the first treatment for opioid use disorder in the US with both weekly and monthly dosing Three million people in the US diagnosed with opioid use disorder LUND, Sweden, May 24, 2023 /PRNewswire/ — Camurus (NASDAQ STO: CAMX) today announces that the US Food and Drug Administration (FDA) has approved Brixadi™ (buprenorphine) extended release … Read more

Cognivia élargit son portefeuille de solutions prédictives en introduisant Compl-AI©™, une solution innovante qui prédit le risque de non-observance et d’abandon des patients

by

Il est prouvé que Compl-AI©™ est capable de prédire les risques de non-observance et d’abandon des traitements. Grâce à Compl-AI, la stratégie de recrutement et d’engagement des patients peut être optimisée pour améliorer les chances des patients. Pour en savoir plus sur Compl-AI, assistez au webinaire Xtalks du 21 juin. MONT-SAINT-GUIBERT, Belgique, 24 mai 2023 /PRNewswire/ … Read more